Animal Health Solutions

Copyright © 2021 Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co., Inc. All rights reserved. US-BRV-210100008 315579 To learn more, contact your Merck Animal Health sales representative. IMPORTANT SAFETY INFORMATION: BRAVECTO 1-MONTH Chews are for dogs 8 weeks of age and older. Side effects may include itching, diarrhea, vomiting, decreased appetite, elevated ALT, lethargy, and weight loss. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. BRAVECTO 1-MONTH Chews are not effective against A. americanum in puppies less than 6 months of age. BRAVECTO Chews for Dogs: The most commonly reported adverse reactions include vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO Chews have not been shown to be effective for 12-weeks' duration in puppies less than 6 months of age. BRAVECTO Chews are not effective against lone star ticks beyond 8 weeks of dosing. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. For complete product information refer to the product insert on page 16. With BRAVECTO® 1-MONTH Chews, BRAVECTO protects dogs across all life stages. Designed for dogs and puppies 8 weeks of age and older, and weighing 4.4 pounds or greater. Once puppies reach 6 months of age, they can then transition to extended-duration BRAVECTO Chews. BRAVECTO 1MONTH CHEWS EXTENDEDDURATION BRAVECTO ® CHEWS LIFE IT'S FOR WITH BRAVECTO & STAY START ®

• Cover